Original SMC news ---- "we do believe that leronlimab could have a significant role in the treatment of MASH, whether as a standalone therapeutic or in a combination therapy approach.”

Ok....today we got 1 side of the potential, to further evaluate "synergies".

This is it....we're now playing in the big leagues of MASH